410 related articles for article (PubMed ID: 35563604)
1. Challenges in Metabolomics-Based Tests, Biomarkers Revealed by Metabolomic Analysis, and the Promise of the Application of Metabolomics in Precision Medicine.
Di Minno A; Gelzo M; Caterino M; Costanzo M; Ruoppolo M; Castaldo G
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563604
[TBL] [Abstract][Full Text] [Related]
2. Metabolomics enables precision medicine: "A White Paper, Community Perspective".
Beger RD; Dunn W; Schmidt MA; Gross SS; Kirwan JA; Cascante M; Brennan L; Wishart DS; Oresic M; Hankemeier T; Broadhurst DI; Lane AN; Suhre K; Kastenmüller G; Sumner SJ; Thiele I; Fiehn O; Kaddurah-Daouk R;
Metabolomics; 2016; 12(10):149. PubMed ID: 27642271
[TBL] [Abstract][Full Text] [Related]
3. The evolving landscape of untargeted metabolomics.
Di Minno A; Gelzo M; Stornaiuolo M; Ruoppolo M; Castaldo G
Nutr Metab Cardiovasc Dis; 2021 Jun; 31(6):1645-1652. PubMed ID: 33895079
[TBL] [Abstract][Full Text] [Related]
4. Metabolomics through the lens of precision cardiovascular medicine.
Lam SM; Wang Y; Li B; Du J; Shui G
J Genet Genomics; 2017 Mar; 44(3):127-138. PubMed ID: 28325553
[TBL] [Abstract][Full Text] [Related]
5. Omics sciences and precision medicine in glioblastoma.
Micheletti C; Bonetti G; Madeo G; Gadler M; Benedetti S; Guerri G; Cristofoli F; Generali D; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Manganotti P; Caruso P; Bernini A; Fulcheri E; Stuppia L; Gatta V; Cecchin S; Marceddu G; Bertelli M
Clin Ter; 2023; 174(Suppl 2(6)):77-84. PubMed ID: 37994751
[TBL] [Abstract][Full Text] [Related]
6. Metabolomics for personalized medicine: the input of analytical chemistry from biomarker discovery to point-of-care tests.
Castelli FA; Rosati G; Moguet C; Fuentes C; Marrugo-Ramírez J; Lefebvre T; Volland H; Merkoçi A; Simon S; Fenaille F; Junot C
Anal Bioanal Chem; 2022 Jan; 414(2):759-789. PubMed ID: 34432105
[TBL] [Abstract][Full Text] [Related]
7. Integration of metabolomics and proteomics in multiple sclerosis: From biomarkers discovery to personalized medicine.
Del Boccio P; Rossi C; di Ioia M; Cicalini I; Sacchetta P; Pieragostino D
Proteomics Clin Appl; 2016 Apr; 10(4):470-84. PubMed ID: 27061322
[TBL] [Abstract][Full Text] [Related]
8. Practicing precision medicine with intelligently integrative clinical and multi-omics data analysis.
Ahmed Z
Hum Genomics; 2020 Oct; 14(1):35. PubMed ID: 33008459
[TBL] [Abstract][Full Text] [Related]
9. The Need for Multi-Omics Biomarker Signatures in Precision Medicine.
Olivier M; Asmis R; Hawkins GA; Howard TD; Cox LA
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561483
[TBL] [Abstract][Full Text] [Related]
10. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
11. Novel personalized pathway-based metabolomics models reveal key metabolic pathways for breast cancer diagnosis.
Huang S; Chong N; Lewis NE; Jia W; Xie G; Garmire LX
Genome Med; 2016 Mar; 8(1):34. PubMed ID: 27036109
[TBL] [Abstract][Full Text] [Related]
12. Personalized Metabolomics.
Marciano DP; Snyder MP
Methods Mol Biol; 2019; 1978():447-456. PubMed ID: 31119679
[TBL] [Abstract][Full Text] [Related]
13. Prospective Metabolomic Studies in Precision Medicine: The AKRIBEA Project.
Bizkarguenaga M; Gil-Redondo R; Bruzzone C; Bernardo-Seisdedos G; Laín A; González-Valle B; Embade N; Mato JM; Millet O
Handb Exp Pharmacol; 2023; 277():275-297. PubMed ID: 36253553
[TBL] [Abstract][Full Text] [Related]
14. Status and perspectives of biomarker validation for diagnosis, stratification, and treatment.
Skov J; Kristiansen K; Jespersen J; Olesen P
Public Health; 2021 Jan; 190():173-175. PubMed ID: 33309006
[TBL] [Abstract][Full Text] [Related]
15. New opportunities from the cancer metabolome.
Aboud OA; Weiss RH
Clin Chem; 2013 Jan; 59(1):138-46. PubMed ID: 23150057
[TBL] [Abstract][Full Text] [Related]
16. Multi-omics strategies for personalized and predictive medicine: past, current, and future translational opportunities.
Ahmed Z
Emerg Top Life Sci; 2022 Apr; 6(2):215-225. PubMed ID: 35234253
[TBL] [Abstract][Full Text] [Related]
17. Omics Biomarkers in Obesity: Novel Etiological Insights and Targets for Precision Prevention.
Aleksandrova K; Egea Rodrigues C; Floegel A; Ahrens W
Curr Obes Rep; 2020 Sep; 9(3):219-230. PubMed ID: 32594318
[TBL] [Abstract][Full Text] [Related]
18. Utilising the precision nutrition toolkit in the path towards precision medicine.
Sawicki C; Haslam D; Bhupathiraju S
Proc Nutr Soc; 2023 Sep; 82(3):359-369. PubMed ID: 37475596
[TBL] [Abstract][Full Text] [Related]
19. Challenges in metabolomics-based disease molecular classification: an analytical perspective.
Gao Y; Liu Q; Xu F
Bioanalysis; 2017 May; 9(10):771-773. PubMed ID: 28520467
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
